GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Devyser Diagnostics DVYSR.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

64.90

+0.15%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

11 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 6Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 168.30

Low
161.60
Average
168.30
Median
168.30
High
178.50

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueSEK 243.9mSEK 297.4mSEK 353.6m
Revenue, highestSEK 246.8mSEK 299.1mSEK 373.8m
Revenue, lowestSEK 241.1mSEK 295.7mSEK 333.4m
Earnings per share0.641.983.38
Earnings per share, highest0.812.213.40
Earnings per share, lowest0.471.743.35
Analysts222

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.070.270.150.430.13-0.10-0.55-0.59
Reported0.440.100.170.82-0.170.08-1.24-0.19
Difference+556.7%-63.0%+14.2%+89.6%-227.0%+177.7%-124.3%+67.6%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -2.4%.

Model fair value

64.63

From earnings 64.63, from revenue 108.57.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.